Boulebd, H.; Ismaili, L.; Bartolini, M.; Bouraiou, A.; Andrisano, V.; Martin, H.; Bonet, A.; Moraleda, I.; Iriepa, I.; Chioua, M.;
et al. Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy. Molecules 2016, 21, 400.
https://doi.org/10.3390/molecules21040400
AMA Style
Boulebd H, Ismaili L, Bartolini M, Bouraiou A, Andrisano V, Martin H, Bonet A, Moraleda I, Iriepa I, Chioua M,
et al. Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy. Molecules. 2016; 21(4):400.
https://doi.org/10.3390/molecules21040400
Chicago/Turabian Style
Boulebd, Houssem, Lhassane Ismaili, Manuela Bartolini, Abdelmalek Bouraiou, Vincenza Andrisano, Helene Martin, Alexandre Bonet, Ignacio Moraleda, Isabel Iriepa, Mourad Chioua,
and et al. 2016. "Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy" Molecules 21, no. 4: 400.
https://doi.org/10.3390/molecules21040400
APA Style
Boulebd, H., Ismaili, L., Bartolini, M., Bouraiou, A., Andrisano, V., Martin, H., Bonet, A., Moraleda, I., Iriepa, I., Chioua, M., Belfaitah, A., & Marco-Contelles, J.
(2016). Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy. Molecules, 21(4), 400.
https://doi.org/10.3390/molecules21040400
